Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-03-06 @ 9:34 AM
Study NCT ID:
NCT06176534
Status:
RECRUITING
Last Update Posted:
2024-08-20
First Post:
2023-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
Sponsor:
Henan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
HNCH-MBC013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None